NielsenIQ (NIQ), a leader in consumer intelligence, today announced it has reached an agreement to acquire Gastrograph AI, a market leading discovery and inquiry platform for sensory insights. The acquisition further strengthens NIQ’s AI capabilities and competitive differentiation to provide CPG companies with the Full View™ of consumer behavior. Gastrograph AI supports some of the largest consumer brands in the world, utilizing predictive AI to develop, test, and reformulate products by mode...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis (CF). With this approval, the indication has been expanded to include all patients ages 2 years and older who have at least one non-class I mutation in the cystic fibrosis conductance regulator (CFTR) gene. “We have been work...